The record
Written from the 1 report below. Nothing here is unsourced.
- The United States has announced a tiered tariff policy on generic drug imports that will take effect from August 1, 2026.
- Under the policy, there will be zero tariffs for two years, rising to 100 percent in 2028 and 200 percent thereafter.
- The stated aim is to boost production of generic medicines within the US.
- The move could affect countries that export generic drugs, including India.
What to watch next
- Details on exemptions or country-specific treatment under the tiered tariff schedule
- Responses from major generic drug exporting countries and manufacturers
- Whether the tariff timeline is implemented as announced from August 1, 2026
Coverage1
1 report
English national1
All filed from India
Named India
The 1 report is listed beside the record.
Ask this story
Answers cite the reports above, or say they can't.